These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2096211)

  • 1. Effect of clonidine on serum inorganic phosphorus in patients with essential arterial hypertension.
    Uza G
    J Hum Hypertens; 1990 Dec; 4(6):687-91. PubMed ID: 2096211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophosphatemia in patients with essential arterial hypertension.
    Uza G
    J Trace Elem Electrolytes Health Dis; 1990 Dec; 4(4):245-8. PubMed ID: 2136290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine-induced hyperglycemia: evidence against a growth hormone-mediated effect.
    Barbieri C; Ferrari C; Caldara R; Testori G; Dal Bo GA; Bertazzoni A
    J Pharmacol Exp Ther; 1980 Aug; 214(2):433-6. PubMed ID: 7391988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and beta-cell hypersecretion in essential hypertension.
    Sechi LA; Tedde R; Marigliano A; Melis A; Pala A; Orecchioni C
    J Hypertens Suppl; 1990 Sep; 8(4):S87-9. PubMed ID: 2258791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of visceral obesity on blood pressure values in patients with essential hypertension].
    Jovanović A; Laganović M; Dika Z; Kos J; Pećin I
    Lijec Vjesn; 2006; 128(11-12):393-5. PubMed ID: 17212205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) secretion during nocturnal sleep and after clonidine in patients with essential hypertension.
    Słowińska-Srzednicka J; Zgliczyński S; Wierzbicki M; Soszyński P; Jeske W
    Clin Exp Hypertens A; 1988; 10(2):187-202. PubMed ID: 3286064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma levels of beta-endorphin and ACTH and serum levels of cortisol in different stages of arterial hypertension before and after clonidine therapy].
    Barletta C; Scavo D
    Minerva Med; 1990 May; 81(5):363-70. PubMed ID: 2165579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.
    Moura E; Afonso J; Serrão MP; Vieira-Coelho MA
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):113-21. PubMed ID: 19067675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clonidine on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Lake CR; Zaloga GP; Coleman MD; Ziegler MG
    Int J Clin Pharmacol Res; 1983; 3(1):9-15. PubMed ID: 6679510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
    Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
    Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans: effects of clonidine.
    Izzo JL; Santarosa RP; Larrabee PS; Smith RJ; Kallay MC
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S225-9. PubMed ID: 2455184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine in mild to moderate hypertension: effects on blood pressure and serum lipoproteins.
    Karlberg BE; Lins LE; Rössner S
    J Hypertens Suppl; 1985 Dec; 3(4):S69-71. PubMed ID: 3913756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and hemodynamic effects of nitrendipine versus clonidine in patients with essential hypertension.
    Stornello M; Valvo EV; Scapellato L; Nazzari M
    Clin Ther; 1986; 8(5):510-9. PubMed ID: 3533265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertensive emergencies: classic and newer approaches.
    Masotti G; Scarti L; Poggesi L; Sciagrà R; Bisi G; Gallini C; Neri Serneri GG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 3():S46-50. PubMed ID: 2429113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine through the skin in the treatment of essential hypertension: is it practical?
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: relationship between echocardiographic findings, blood pressure, and urinary catecholamines.
    Timio M; Venanzi S; Gentili S; Ronconi M; Del Re G; Del Vita M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S142-6. PubMed ID: 2455168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.